两阶段交换关节成形术后短期口服抗生素似乎可降低早期再感染
回顾性分析444例因假体周围感染行两阶段交换关节成形术的患者,按再植入后口服抗生素疗程分为无抗生素组(102例)、≤2周组(266例)和>2周组(76例)。再植入后1年内共发生34例再感染,≤2周组再感染率低于无抗生素组(HR 0.38,P=0.01),口服抗生素总体降低再感染率(HR 0.39,P=0.01)。
要点
- 再植入后1年内再感染率:无抗生素组14.1%、≤2周组7.0%、>2周组6.4%。
- ≤2周组较无抗生素组再感染风险降低(HR 0.38,P=0.01)。
- 口服抗生素总体(≤2周与>2周合并)降低再感染率(HR 0.39,P=0.01)。
核心结论
- 数据支持再植入后短期口服抗生素可降低1年再感染率的假说。
- 未来随机研究应探讨不同口服抗生素疗程的疗效以降低再感染。
研究设计与样本
- 回顾性综述纳入因髋或膝关节假体周围感染行两阶段交换关节成形术的患者。
- 排除既往两阶段交换失败、再植入时培养阳性、术后长期静脉抗生素和/或终身抑制治疗者,最终纳入444例再植入(210髋和234膝)。
- 按再植入后口服抗生素疗程分为无抗生素组(102例)、≤2周组(266例)和>2周组(76例),主要终点为再植入后1年内再感染。
主要发现
- 再植入后1年内共发生34例再感染。
- 无抗生素组、≤2周组和>2周组再感染率分别为14.1%、7.0%和6.4%。
- 多变量Cox回归显示≤2周组较无抗生素组再感染率降低(HR 0.38,P=0.01)。
- >2周组样本量较小,未显著降低再感染率(HR 0.41,P=0.12)。
- ≤2周组与>2周组合并后,使用口服抗生素总体降低再感染率(HR 0.39,P=0.01)。
关键数值与推荐
- 再感染率:无抗生素组14.1%、≤2周组7.0%、>2周组6.4%。
- ≤2周组 vs 无抗生素组再感染HR 0.38(P=0.01)。
- >2周组 vs 无抗生素组再感染HR 0.41(P=0.12)。
- 口服抗生素合并组 vs 无抗生素组再感染HR 0.39(P=0.01)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 证据等级为预后Level IV。
- >2周组样本量较小,其再感染率降低未达统计学显著(HR 0.41,P=0.12)。
- 未来需随机研究探讨不同口服抗生素疗程的疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recent evidence has suggested a benefit to extended postoperative prophylactic oral antibiotics after two-stage exchange arthroplasty for treatment of periprosthetic joint infections. We sought to determine reinfection rates with and without a short course of oral antibiotics after two-stage exchange procedures. METHODS: A retrospective review identified patients undergoing two-stage exchange arthroplasty for periprosthetic joint infection of the hip or knee. Patients were excluded if they failed a prior two-stage exchange, had positive cultures at reimplantation, prolonged intravenous antibiotics postoperatively, and/or life-long suppression. This resulted in 444 reimplantations (210 hips and 234 knees). Patients were divided into three cohorts based on the duration of oral antibiotics after reimplantation: no antibiotics (102), ≤2 weeks (266), or >2 weeks (76). The primary endpoint was reinfection within 1 year of reimplantation. RESULTS: Within 1 year of reimplantation, there were 34 reinfections. In the no-antibiotic, ≤ 2-week, and >2-week cohorts the reinfection rates were 14.1, 7.0, and 6.4%, respectively. Multivariate Cox regression showed a reduced reinfection rate in the ≤2-week cohort relative to no antibiotics (hazard ratio [HR]: 0.38, P = .01). While the smaller cohort with >2 weeks of antibiotics did not significantly reduce the reinfection rate (HR: 0.41, P = .12), when combined with the ≤2-week cohort, use of oral antibiotics had an overall reduction of the reinfection rate (HR: 0.39, P = .01). CONCLUSIONS: These data support the hypothesis that a short course of oral antibiotics after reimplantation decreases the 1-year reinfection rate. Future randomized studies should seek to examine the efficacy of different durations of oral antibiotics to reduce reinfection. LEVEL OF EVIDENCE: Prognostic Level IV.
引用
- Ryan SP, Warne CN, Osmon DR, et al. Short Course of Oral Antibiotic Treatment After Two-Stage Exchange Arthroplasty Appears to Decrease Early Reinfection. J Arthroplasty. 2022. PMID: 36496045. doi:10.1016/j.arth.2022.12.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。